|
JPH11137640A
|
|
Method for granulating crude medicines
|
|
JPH09249563A
|
|
Tizanidin-containing composition
|
|
JPH07109226A
|
|
Preventive and therapeutic agent for cancer
|
|
JPH0710756A
|
|
Sustained release preparation of nicardipine hydrochloride
|
|
JPH0710758A
|
|
Long acting cefaclor pharmaceutical preparation
|
|
JPH06135961A
|
|
New diphynelpyrrolylfuran derivative
|
|
JPH0632737A
|
|
Sustained release nifedipine preparation and its production
|
|
JPH0625230A
|
|
Cephem derivative and its production
|
|
JPH05247015A
|
|
New piperazine derivative
|
|
JPH03161460A
|
|
Treating agent for improvement of pancreas function
|
|
JPH0259522A
|
|
Improver for cerebral metabolism and/or mental symptom
|
|
EP0320532A1
|
|
Novel optically active carboxylic acid derivative l-lysine salt and process for production thereof
|
|
FI875522A0
|
|
Nytt optiskt aktivt l-lysinsalt av ett karboxylsyraderivat och foerfarande foer framstaellning av detsamma.
|
|
JPH01128975A
|
|
Production of 1, 5-benzothiazepin derivative
|
|
JPS6461447A
|
|
(+-)-or (+)-1-(2-n-substituted aminoethyl)-1-methyl-7-methoxy-1,2,3,4-tetrahydronaphthalene and production thereof
|
|
JPS63307866A
|
|
Production of 1,5-benzothiazepine derivative
|
|
JPS6322556A
|
|
Novel optically active carboxylic acid derivative l-lysine salt and its preparation
|
|
JPS6322044A
|
|
1,2-dihydronaphthalene derivative and production thereof
|
|
JPS632972A
|
|
Novel prostaglandin e1 derivative and production thereof
|
|
JPS62294638A
|
|
Novel benzoylpropionic acid derivative and production thereof
|
